First Update on this on-going epidemic in 2019 shows that the cumulative number of cases has now passed 600 - NO CCOMPLACENCY!. No country can afford to be complacent about this epidemic as long as it persists.
READ ON -
‘EPIDEMIOLOGICAL SITUATION IN THE PROVINCES OF NORTH KIVU AND ITURI
Wednesday, January 2, 2019
The epidemiological situation of the Ebola Virus Disease dated January 1, 2019:
Since the beginning of the epidemic, the cumulative number of cases is 608, of which 560 are confirmed and 48 are probable. In total, there were 368 deaths (320 confirmed and 48 probable) and 207 people cured.
29 suspected cases under investigation.
6 new confirmed cases, 2 in Butembo, 2 in Katwa and 2 in Beni.
2 new deaths of confirmed cases in Beni.
2 new people healed out of Butembo CTE.
The data presented in this table are subject to further changes after thorough investigations and after redistribution of cases and deaths in their respective health areas.
To avoid that the total number of cases varies (up or down) daily, the suspect cases have been placed in a separate category. Thus, suspect cases with positive laboratory tests will be added to the confirmed category, while negative ones (non-cases) will be removed from the table.
The probable case category includes all reported deaths for which it was not possible to obtain biological samples for laboratory confirmation. The investigations will determine whether these deaths are related to the epidemic or not.
A community death is a death in the community, outside of a licensed health center.
News of the response
Since the start of vaccination on August 8, 2018, 54,153 people have been vaccinated, including 19,363 in Beni, 10,761 in Katwa, 5,977 in Butembo, 5,377 in Mabalako, 2,258 in Kalunguta, 1,663 in Mandima, 1,388 in Komanda, 1,009 in Oicha, 942 in Goma, 791 in Vuhovi, 750 in Masereka, 700 in Lubero, 659 in Kyondo, 599 in Mutwanga, 434 in Bunia, 394 in Musienene, 360 in Karisimbi, 355 in Tchomia, 167 in Nyankunde, 70 in Biena, 63 in Alimbongo, and 13 in Kisangani.
The only vaccine to be used in this outbreak is the rVSV-ZEBOV vaccine, manufactured by the pharmaceutical group Merck, following approval by the Ethics Committee in its decision of 19 May 2018.’’
EBOLA RDC - Evolution de la riposte contre l'épidémie d'Ebola dans les provinces du Nord Kivu et de l'Ituri au Mercredi 2 janvier 2019 ‘
AFRICA CENTRE FOR CLINICAL GOVERNANCE RESEARCH & PATIENT SAFETY
@Health Resources International (HRI) WA.
National Implementing Organisation: 12-Pillar Clinical Governance
National Implementing Organisation: PACK Nigeria Programme for PHC
Publisher: Medical and Health Journals; Books and Periodicals.
Nigeria: 8 Amaku Street, State Housing & 20 Eta Agbor Road, Calabar.
Tel: +234 (0) 8063600642
Website: www.hriwestafrica.com email: email@example.com ; firstname.lastname@example.org
HIFA profile: Joseph Ana is the Lead Consultant and Trainer at the Africa Centre for Clinical Governance Research and Patient Safety in Calabar, Nigeria. In 2015 he won the NMA Award of Excellence for establishing 12-Pillar Clinical Governance, Quality and Safety initiative in Nigeria. He has been the pioneer Chairman of the Nigerian Medical Association (NMA) National Committee on Clinical Governance and Research since 2012. He is also Chairman of the Quality & Performance subcommittee of the Technical Working Group for the implementation of the Nigeria Health Act. He is a pioneer Trustee-Director of the NMF (Nigerian Medical Forum) which took the BMJ to West Africa in 1995. He is particularly interested in strengthening health systems for quality and safety in LMICs. He has written Five books on the 12-Pillar Clinical Governance for LMICs, including a TOOLS for Implementation. He established the Department of Clinical Governance, Servicom & e-health in the Cross River State Ministry of Health, Nigeria in 2007. Website: www.hriwestafrica.com Joseph is a member of the HIFA Steering Group: http://www.hifa.org/people/steering-group
jneana AT yahoo.co.uk